KLTO Stock Price | Klotho Neurosciences, Inc. P/E, Revenue, EPS, & Forecasts

Klotho Neurosciences, Inc. • KLTO

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Klotho Neurosciences, Inc.

Ticker

KLTO

Trading on

NASDAQ

ISIN

US49876K1034

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Joseph Sinkule Pharm.D.

Headquarters

13576 Walnut Street, Omaha, NE, United States, 68144

Employees

Website

https://klothoneuro.com

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Metrics

BasicAdvanced

Market cap

$34.5M

P/E ratio

EPS

-$0.30

Dividend Yield

0.00%

Beta

2.41

Forward P/E ratio

EBIDTA

Ex dividend date

Price & volume

Market cap

$34.5M

Average daily volume

0.7M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

3.48

Earnings

EPS

-$0.30

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

2.41

52-week High

$2.45

52-week Low

$0.11

50-day moving average

$0.52

200-day moving average

$0.59

Short ratio

0.57

Short %

0.80%

Management effectiveness

ROE (TTM)

-198.28%

ROA (TTM)

-71.63%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

72.5M

Float

59M

Insiders %

21.24%

Institutions %

2.62%

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.08

Q4 • 24Beat

-$0.08

Q1 • 25Beat

-$0.12

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-4.1M

-∞%

Q2 • 25

$0M

$-2.9M

-∞%

Q3 • 25

NaN%

-29.26%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$10.8M

$0.2M

1.80%

Q2 • 25

$10.1M

$0.1M

1.45%

Q3 • 25

-7.12%

-25.34%

-19.61%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-2M

$0M

$9.8M

$-2M

Q2 • 25

$-1.1M

$0M

$-1.1M

Q3 • 25

-44.72%

-99.95%

-44.72%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Klotho Neurosciences, Inc. share?

Klotho Neurosciences, Inc. shares are currently traded for undefined per share.

How many shares does Klotho Neurosciences, Inc. have?

Klotho Neurosciences, Inc. currently has 72.5M shares.

Does Klotho Neurosciences, Inc. pay dividends?

No, Klotho Neurosciences, Inc. doesn't pay dividends.

What is Klotho Neurosciences, Inc. 52 week high?

Klotho Neurosciences, Inc. 52 week high is $2.45.

What is Klotho Neurosciences, Inc. 52 week low?

Klotho Neurosciences, Inc. 52 week low is $0.11.

What is the 200-day moving average of Klotho Neurosciences, Inc.?

Klotho Neurosciences, Inc. 200-day moving average is $0.59.

Who is Klotho Neurosciences, Inc. CEO?

The CEO of Klotho Neurosciences, Inc. is Dr. Joseph Sinkule Pharm.D..

How many employees Klotho Neurosciences, Inc. has?

Klotho Neurosciences, Inc. has 3 employees.

What is the market cap of Klotho Neurosciences, Inc.?

The market cap of Klotho Neurosciences, Inc. is $34.5M.

What is the P/E of Klotho Neurosciences, Inc.?

The current P/E of Klotho Neurosciences, Inc. is null.

What is the EPS of Klotho Neurosciences, Inc.?

The EPS of Klotho Neurosciences, Inc. is -$0.30.

What is the PEG Ratio of Klotho Neurosciences, Inc.?

The PEG Ratio of Klotho Neurosciences, Inc. is null.